Since 2005, China’s dietary supplement (health food) industry has presented rapid development trend and the market demand also increases continuously. In 2012, the scale of dietary supplement industry has reached CNY 158.4 billion, ranked the second all over the world. However, as for the product distribution and sales channels, China’s dietary supplement industry is still in the initial stage in the development history of European and American markets.

According to the statistics of China Health Care Association, there were 2025 dietary supplement enterprises in China by H1 of 2012. According to the survey of 2951 kinds of dietary supplements, it’s found that 767 of them are counterfeit products. The reason is that the huge market potential and serious buyer’s market nature lead to high gross profit margin (as high as 200%) in China’s dietary supplement industry, which lead to the enterprises with varying qualities coexist in this industry.

This report mainly includes the following aspects: policy environment, industry status quo, market scale, development in key regions, import and export characteristics, development trend, investment opportunities and investment risks; and also pays particular emphasis on eight key enterprises. In addition, this report also analyzes the industry existing problems, influencing factors and consumer demand characteristics.

Table Of Contents

Research and Forecast of China’s Dietary Supplement (Health Food) Industry, 2013-2017
Table of Contents

1. Overview of China's Dietary Supplement Industry
1.1 Basic Conception
1.1.1 Product Definition
1.1.2 Product Classification
1.1.3 Difference with Other Foods
1.1.4 Difference with Medicines
1.1.5 Consumption Value
1.2 Development History
1.3 Market Characteristics

2. Development Environment of Dietary Supplement Industry
2.1 Economic Environment
2.1.1 Economic Development Status
2.1.2 GDP
2.1.3 Investment in the Fixed Assets
2.1.4 Total Export-Import Volume and the Growth Rate
2.2 Social Environment
2.3 Policy Environment
2.3.1 Important Laws and Regulations
2.3.2 Gradual Tightened Policy Supervision
2.3.3 Interpretation of the “Twelfth Five-Year” Plan

3. Status Quo of China's Dietary Supplement Industry
3.1 Market Status Quo
3.2 Consumption Demand
3.2.1 Powerful Demand and Huge Potential
3.2.2 Three Directions
3.2.3 Common Sense Shortage of Consumers
3.2.4 The Consumer Group becomes Younger
3.2.5 Consumption Spending
3.2.6 Consumption Concentration Ratio
3.3 Distribution Channel
3.4 Factors Affecting the Industrial Development
3.4.1 Macroscopic Positive Factors
3.4.2 Constraints
3.5 Main Existing Problems
3.5.1 Weak Research Technical Force
3.5.2 Backward Production Technology
3.5.3 Inadequate Production-Learning Combination Strength
3.5.4 Lack of High-level Professionals
3.5.5 Weak Market Supervision
3.5.6 Confused Knowledge to Dietary Supplements and Inadequate Health Knowledge
3.6 Market Segments

4. Development in Key Provinces
4.1 Zhejiang—Distributing Center of Dietary Supplements; Hidden Worries behind the Prosperity
4.2 Jiangsu—Innovative Supervision Model; Standardized Enterprise Management
4.3 Shanghai—Supervision with Strong Pertinence; Powerful and Positive Measures
4.4 Shaanxi—Obvious Resource Advantages; Huge Development Potential
4.5 Beijing—Strong Scientific and Technological Strength; Flourishing Industry Development

5. Imports and Exports of China's Dietary Supplements
5.1 Characteristics
5.2 Import and Export Statistics

6. Key Enterprises in China's Dietary Supplement Industry
6.1 Amway
6.1.1 Company Profile
6.1.2 Business Performance
6.1.3 Competitiveness
6.1.4 Future Development
6.2 Jing Brand Co., Ltd.
6.2.1 Company Profile
6.2.2 Business Performance
6.2.3 Competitiveness
6.2.4 Development Strategy
6.3 Perfect (China) Co., Ltd.
6.3.1 Company Profile
6.3.2 Business Performance
6.3.3 Competitiveness
6.4 New Era Health Industry (Group) Co., Ltd.
6.4.1 Company Profile
6.4.2 Business Performance
6.4.3 Competitiveness
6.4.4 Development Strategy
6.5 Shanghai Jiao Da Onlly Co., Ltd.
6.5.1 Company Profile
6.5.2 Business Performance
6.5.3 Competitiveness
6.5.4 Development Strategy
6.6 Joincare Pharmaceutical Industry Group Co., Ltd.
6.6.1 Company Profile
6.6.2 Business Performance
6.6.3 Competitiveness
6.6.4 Development Strategy
6.7 By-Health
6.7.1 Company Profile
6.7.2 Business Performance
6.7.3 Competitiveness
6.7.4 Future Development
6.8 Gonge Ejiao
6.8.1 Company Profile
6.8.2 Business Performance
6.8.3 Competitiveness
6.8.4 Development Strategy

7. Development Trend of China's Dietary Supplement Industry
7.1 The Industry Accelerate Market Expansion, Sales Scale Will Be Doubled
7.2 Research Categories Upgrade, Quality Competitions Become Fiercer
7.3 Standard System is Completed, Industry Revolution is Accelerated
7.4 Unprecedented Supervision Strength, Disordered Situations Disappeared
7.5 Consumer Psychology Becomes Mature, Consumer Market is Expanded

8. Investment Opportunity and Investment Risk
8.1 SWOT
8.2 Investment Opportunity in Industry Segments
8.3 Industry Risk
8.3.1 Risk from Technological Level
8.3.2 Risk from Competitive Landscape
8.3.4 Risk from Export Factors
8.4 Suggestions from Experts




Companies Mentioned

Amway
Jing Brand Co., Ltd.
Perfect (China) Co., Ltd.
New Era Health Industry (Group) Co., Ltd.
Shanghai Jiao Da Onlly Co., Ltd.
Joincare Pharmaceutical Industry Group Co., Ltd.
By-Health
Gonge Ejiao

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

The Future of IT in the Healthcare Industryin North America, Latin America, and Europe : An End-user Perspective

The Future of IT in the Healthcare Industryin North America, Latin America, and Europe : An End-user Perspective

  • $ 12 500
  • Industry report
  • January 2015
  • by Frost & Sullivan

Research Objectives The overall research objective is to measure the current use and future decision making behavior towards information technology (IT) within the healthcare industry for smartphones, ...

2015 Global Outlook of the Healthcare Industry : Digitization, Decentralization and Democratization of Healthcare

2015 Global Outlook of the Healthcare Industry : Digitization, Decentralization and Democratization of Healthcare

  • $ 10 000
  • Industry report
  • March 2015
  • by Frost & Sullivan

In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provide bold perspectives and predictions for the industry in 2015. The markets covered include pharmaceuticals ...

Sirolimus  - Comprehensive patent search

Sirolimus - Comprehensive patent search

  • $ 10 118
  • Industry report
  • March 2015
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Ulcerative Colitis: Kol Insight

December 2014 $ 8 119

Download Unlimited Documents from Trusted Public Sources

Pharmacy Statistics in the UK

  • April 2015
    145 pages
  • Pharmaceutical  

    Pharmacy  

    Medicine  

  • United Kingdom  

    Europe  

View report >

Pharmacy Industry in the UK

  • April 2015
    125 pages
  • Pharmacy  

    Community Pharm...  

    Occupational He...  

  • United Kingdom  

    Europe  

    United States  

View report >

Pathology Description in the UK

  • April 2015
    132 pages
  • Mental Health  

    Mental Illness  

    Obesity  

  • United Kingdom  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.